Willis has followed through on recent signals that it has M&A funds available with the acquisition of Tranzact, a direct-to-consumer healthcare broker, for a price that one estimate said implies 23.7x trailing earnings.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: